Lines of business

Regional

bubble-lines_Generics

Our focus is on bringing high quality, difficult to make generic products to selected markets in America, CEE and Asia.

Alvogen has established experienced teams and commercial presence in all of our key markets in the US, CEE and Asia.

Currently with about 900 SKUs MAAs authorizations under submissions and more than 50 ANDA filings in the USA under way.

The portfolio includes all major therapeutic areas such as cardiovascular, CNS, Oncology, Respiratory and Biosimilars.

Leveraging local know-how and vast portfolio, Alvogen is growing its presence and capturing market share with multiple new product launches in all key markets.

Contract Research

Our experienced CRO team offers fully accredidated clinical- and Pharmacovigilance services third party customers.

Norwich Clinical Services (NCS) is a part of Alvogen’s third party services

Located in Bangalore India with an exceptional team of experienced scientists and managers.

NCS provides bioequivalence, bio analytical and clinical service as well as pharmacovigilance services.

bubble-lines_research

Contract Manufacturing

bubble-lines_manufacturing

Long tradition of contract Manufacturing for both originators as well as companies operating in the generic industry.

With over 125 year history Norwich provides contract manufacturing and product development services to third party customers including Pfizer, Schering-Plough, Abbott, P&G, Mayer Laboratories and Iroko Parmaceuticals

Outstanding quality record remaining without a single 483 from FDA for the last 20 years.

NPI capabilities finished dose form manufacturing and packaging include tablets, capsules, liquids, semi-solids, and sponges.

Management team with a proven track record 

Alvogen’s leadership team is dedicated to fostering a dynamic change-driven culture committed to meeting the needs of our customers. Our organizational structure is lean and flexible, driving quick and effective decision making and thus enabling the company to bring new generic products quickly and safely to market. At the same time, our structure empowers the organization to collaborate with customers and suppliers on finding the best possible solution every time.

Country managers and business unit leaders drive continuous improvement and are responsible for business development and customer service levels across their regions. They are supported by global and regional portfolio, quality, supply chain and regulatory teams and local support services. 

The executive leadership team forms the Alvogen Management Board, and includes the Chairman & CEO, CEO America, Chief Financial Officer (CFO), Chief Operating Officer (COO), Global Executive of Organizational Development (COD), EVP of Sales in the CEE region, EVP of Sales in APAC, EVP of Business Development and Chief Legal Council.